𝔖 Bobbio Scriptorium

✦ LIBER ✦

45-1 - Cognitive dysfunction in schizophrenia — Neuropathological origins and prospects for treatment

✍ Scribed by D.R. Weinberger

Book ID: 118511891
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 265 KB
Volume: 42
Category: Article
ISSN: 0006-3223
DOI: 10.1016/s0006-3223(97)87435-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AVE1625, a cannabinoid CB1 receptor anta

AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents

✍ Mark D. Black; Rachel J. Stevens; Nancy Rogacki; Robert E. Featherstone; Yaw Sen 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 420 KB

Discovery of N-[(3R)-1-Azabicyclo[2.2.2]

Discovery of N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship

✍ Wishka, Donn G.; Walker, Daniel P.; Yates, Karen M.; Reitz, Steven C.; Jia, Shao 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 200 KB